Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 7/2020

01-07-2020 | Care | Review

Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk

Authors: R.T.A.L. de Bot, H.D. Veldman, A.M. Witlox, L.W. van Rhijn, M. Hiligsmann

Published in: Osteoporosis International | Issue 7/2020

Login to get access

Abstract

Cost-effective preventive interventions are necessary for tackling the increasing number of hip fractures, which are frequently occuring as a serious consequence of osteoporosis. Several interventions have been available for preventing and treating osteoporosis. The aim of this study was to systematically review and critically appraise studies that assessed cost-effectiveness of hip protectors for the prevention of hip fractures and to investigate the effects of age, gender and residence situation on cost-effectiveness. A systematic review was conducted in order to identify economic evaluation studies examining the hip protector solely or compared to no treatment according to the Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Synthesis of results was performed to observe trends between the studies. Methodological quality of the studies was assessed by the use of the Quality of Health Economic Studies (QHES) instrument. A total of 15 economic evaluation studies were included for analysis. The methodological quality was high in most studies (13/15). The hip protector was solely evaluated in three studies and within 12 other studies compared with no intervention. All studies that investigated the cost-effectiveness in long-term care facilities revealed that hip protector use is a cost-effective strategy for the prevention of hip fractures in elderly. Cost-effectiveness was also observed in two studies that provided hip protectors in a geriatric hospital ward. Four studies included both community-dwelling residents and residents living in a long-term care facility in their study. These studies showed more variability regarding cost-effectiveness. One study did not report information regarding the residence situation of their cohort, but also observed cost-effectiveness. In conclusion, this review suggests that hip protectors are a cost-effective approach in the prevention of hip fractures in populations with high risk of hip fractures especially in long-term care facilities and a geriatric ward in a hospital.
Literature
1.
Sözen T, Ozisik L, Basaran NC (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46–56PubMedCrossRef
2.
Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the international osteoporosis foundation (IOF) and the european federation of pharmaceutical industry associations (EFPIA). Arch Osteoporos 8(136):1–115
3.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465–475PubMedCrossRef
4.
Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, Hoffman S, Kaplan F (1991) Risk factors of falls as a cause of hip fracture in women. N Engl J Med 324(19)
5.
Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatri Soc 51(3):364–370CrossRef
6.
7.
Haentjes P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152(6):380–390CrossRef
8.
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet. 359(9319):1761–1767CrossRefPubMed
9.
Veldman HD, Heyligers IC, Grimm B, Boymans TA (2017) Cemented versus cementless hemiarthroplasty for a displaced fracture of the femoral neck: a systematic review and meta-analysis of current generation hip stems. Bone Joint J 99-B(4):421–431PubMedCrossRef
10.
Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world wide projection. Osteoporos Int 2(6):285–289PubMedCrossRef
11.
Johnell O, Gullberg B, Allander E, Kanis JA, Group MS (1992) The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporos Int 2(6):298–302PubMedCrossRef
12.
Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N Engl J Med 332(12):767–773PubMedCrossRef
13.
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 312(7041):1254–1259PubMedPubMedCentralCrossRef
14.
Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, Dequeker J, Dilsen G, Gennari C, Vaz AL, Lyritis G, Mazzuoli G, Miravet L, Passeri M, Perez Cano R, Rapado A, Ribot C (1999) Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean osteoporosis study. Osteoporos Int 9(1):45–54PubMedCrossRef
15.
Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G (1995) Risk factors for hip fracture in European women: the MEDOS study. Mediterranean osteoporosis study. J Bone Miner Res 10(11):1802–1815PubMedCrossRef
16.
Rubenstein LZ (2006) Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing 35 Suppl 2:ii37–ii41PubMedCrossRef
17.
Finsterwald M, Sidelnikov E, Orav EJ, Dawson-Hughes B, Theiler R, Egli A, Platz A, Simmen HP, Meier C, Grob D, Beck S, Stähelin HB, Bischoff-Ferrari HA (2014) Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older. Osteoporos Int 25(1):167–176PubMedCrossRef
18.
Sugarman JR, Connell FA, Hansen A, Helgerson SD, Jessup MC, Lee H (2002) Hip fracture incidence in nursing home residents and community-dwelling older people, Washington State, 1993-1995. J Am Geriatr Soc 50(10):1638–1643PubMedCrossRef
19.
Kannus P, Sievanen H, Palvanen M, Järvinen T, Parkkari J (2005) Prevention of falls and consequent injuries in elderly people. Lancet. 366(9500):1885–1893PubMedCrossRef
20.
Gass M, Dawson-Hughes B (2006) Preventing osteoporosis-related fractures: an overview. Am J Med 119(4 Suppl 1):S3–S11PubMedCrossRef
21.
Riggs BL, Melton LJ 3rd (1992) The prevention and treatment of osteoporosis. N Engl J Med 327(9):620–627PubMedCrossRef
22.
Howe TE, Shea B, Dawson LJ, Downie F, Murray A, Ross C, Harbour RT, Caldwell LM, Creed G (2011) Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 7:CD000333
23.
Santesso N, Carrasco-Labra A, Brignardello-Petersen R (2014) Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 3:CD001255
24.
Cumming RG, Klineberg RJ (1994) Case-control study of risk factors for hip fractures in the elderly. Am J Epidemiol 139(5):493–503PubMedCrossRef
25.
Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ (1985) Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178–208PubMedCrossRef
26.
van Schoor NM, van der Veen AJ, Schaap LA, Smit TH, Lips P (2006) Biomechanical comparison of hard and soft hip protectors, and the influence of soft tissue. Bone. 39(2):401–407PubMedCrossRef
27.
Laing AC, Robinovitch SN (2008) Effect of soft shell hip protectors on pressure distribution to the hip during sideways falls. Osteoporos Int 19(7):1067–1075PubMedCrossRef
28.
Minns RJ, Marsh AM, Chuck A, Todd J (2007) Are hip protectors correctly positioned in use? Age Ageing 36(2):140–144PubMedCrossRef
29.
Cianferotti L, Fossi C, Brandi ML (2015) Hip protectors: are they worth it? Calcif Tissue Int 97(1):1–11PubMedCrossRef
30.
Cameron ID, Robinovitch S, Birge S, Kannus P, Khan K, Lauritzen J, Howland J, Evans S, Minns J et al (2010) Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II). Osteoporos Int 21(1):1–10PubMedPubMedCentralCrossRef
31.
Gillespie WJ, Gillespie LD, Parker MJ (2010) Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 10:CD001255
32.
Parker MJ, Gillespie LD, Gillespie WJ (2003) Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev 3:CD001255
33.
Parker MJ, Gillespie WJ, Gillespie LD (2006) Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ. 332(7541):571–574PubMedPubMedCentralCrossRef
34.
Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, Vanoli A, Martin FC, Gosney MA (2007) Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ. 334(7584):82PubMedCrossRef
35.
Korall AM, Feldman F, Scott VJ, Wasdell M, Gillan R, Ross D, Thompson-Franson T, Leung PM, Lin L (2015) Facilitators of and barriers to hip protector acceptance and adherence in long-term care facilities: a systematic review. J Am Med Dir Assoc 16(3):185–193PubMedCrossRef
36.
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):1–6CrossRef
37.
Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, Wade SW, Hay JW (2003) Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm 9(1):53–61PubMed
38.
Chiou CF, Hay JW, Wallace JF, Bloom BS, Neumann PJ, Sullivan SD, Yu HT, Keeler EB, Henning JM, Ofman JJ (2003) Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care 41(1):32–44PubMedCrossRef
39.
Spiegel BM, Targownik LE, Kanwal F, Derosa V, Dulai GS, Grainek IM, Chlou CF (2004) The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal. Gastroenterology. 127(2):403–411PubMedCrossRef
40.
41.
Segui-Gomez M, Keuffel E, Frick KD (2002) Cost and effectiveness of hip protectors among the elderly. Int J Technol Assess Health Care 18(1):55–66PubMed
42.
Colon-Emeric CS, Datta SK, Matchar DB (2003) An economic analysis of external hip protector use in ambulatory nursing facility residents. Age Ageing 32(1):47–52PubMedCrossRef
43.
Waldegger L, Cranney A, Man-Son-Hing M, Coyle D (2003) Cost-effectiveness of hip protectors in institutional dwelling elderly. Osteoporos Int 14(3):243–250PubMedCrossRef
44.
Fleurence RL (2004) Cost-effectiveness of fracture prevention treatments in the elderly. Int J Technol Assess Health Care 20(2):184–191PubMedCrossRef
45.
Singh S, Sun H, Anis AH (2004) Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol 31(8):1607–1613PubMed
46.
van Schoor NM, de Bruyne MC, van der Roer N, Lommerse E, van Tulder MW, Bouter LM, Lips P (2004) Cost-effectiveness of hip protectors in frail institutionalized elderly. Osteoporos Int 15(12):964–969PubMedCrossRef
47.
Meyer G, Wegscheider K, Kersten JF, Icks A, Muhlhauser I (2005) Increased use of hip protectors in nursing homes: economic analysis of a cluster randomized, controlled trial. J Am Geriatr Soc 53(12):2153–2158PubMedCrossRef
48.
Honkanen LA, Schackman BR, Mushlin AI, Lachs MS (2005) A cost-benefit analysis of external hip protectors in the nursing home setting. J Am Geriatr Soc 53(2):190–197PubMedCrossRef
49.
Honkanen LA, Mushlin AI, Lachs M, Schackman BR (2006) Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations? J Am Geriatr Soc 54(11):1658–1665PubMedCrossRef
50.
Sawka AM, Gafni A, Boulos P, Beattie K, Papaioannou A, Cranney A, Hanley DA, Adachi JD, Cheung A, Papadimitropoulos EA, Thabane L (2007) Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care? The case of Ontario, Canada. Osteoporos Int 18(6):819–827PubMedCrossRef
51.
Gandjour A, Weyler EJ (2008) Cost-effectiveness of preventing hip fractures by hip protectors in elderly institutionalized residents in Germany. Value Health 11(7):1088–1095PubMedCrossRef
52.
Stollenwerk B, Waldeyer R, Klein-Meding C, Muller D, Stock S (2014) Cost effectiveness of external hip protectors in the hospital setting: a modeling study. Nurs Econ 32(2):89–98PubMed
53.
Stollenwerk B, Bartmus T, Klug F, Stock S, Muller D (2015) Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model. Osteoporos Int 26(4):1367–1379PubMedCrossRef
54.
Church JL, Haas MR, Goodall S (2015) Cost effectiveness of falls and injury prevention strategies for older adults living in residential aged care facilities. Pharmacoeconomics. 33(12):1301–1310PubMedCrossRef
55.
Cohen DJ, Reynolds MR (2009) Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol 52(25):2119–2126CrossRef
56.
Polinder S, Segui-Gomez M, Toet H, Belt E, Sethi D, Racioppi F, van Beeck EF (2012) Systematic review and quality assessment of economic evaluation studies of injury prevention. Accid Anal Prev 45:211–221PubMedCrossRef
57.
58.
Mastrigt GA, Hiligsmann M, Arts JJ, Broos PH, Kleijnen J, Evers SM, Majoie MH (2016) How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Rev Pharmacoecon Outcomes Res 16(6):689–704PubMedCrossRef
59.
Chan DK, Hillier G, Coore M, Cooke R, Monk R, Mills J, Hung WT (2000) Effectiveness and acceptability of a newly designed hip protector: a pilot study. Arch Gerontol Geriatr 30(1):25–34PubMedCrossRef
60.
Ekman A, Mallmin H, Michaelsson K, Ljunghall S (1997) External hip protectors to prevent osteoporotic hip fractures. Lancet. 350(9077):563–564PubMedCrossRef
61.
Kannus P, Parkkari J, Niemi S, Pasanen M, Palvanen M, Jarvinen M, Vuori I (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343(21):1506–1513PubMedCrossRef
62.
Lauritzen JB, Petersen MM, Lund B (1993) Effect of external hip protectors on hip fractures. Lancet. 341(8836):11–13PubMedCrossRef
63.
Cameron ID, Murray GR, Gillespie LD, Robertson MC, Hill KD, Cumming RG, Kerse N (2010) Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 1:CD005465
64.
Garrison LP Jr, Pauly MV, Willke RJ, Neumann PJ (2018) An overview of value, perspective, and decision context-a health economics approach: an ISPOR special task force report [2]. Value Health 21(2):124–130PubMedCrossRef
65.
Strand Bergmo T (2015) How to measure costs and benefits of ehealth interventions: an overview of methods and frameworks. J Med Internet Res 17(11):254CrossRef
66.
Cameron ID, Gillespie LD, Robertson MC, Murray GR, Hill KD, Cumming RG, Kerse N (2012) Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 12:CD005465PubMed
67.
Neyens JC, van Haastregt JC, Dijcks BP, Martens M, van den Heuvel WJ, de Witte LP, Schols JM (2011) Effectiveness and implementation aspects of interventions for preventing falls in elderly people in long-term care facilities: a systematic review of RCTs. J Am Med Dir Assoc 12(6):410–425PubMedCrossRef
68.
Muller D, Borsi L, Stracke C, Stock S, Stollenwerk B (2015) Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes. Eur J Health Econ 16(5):517–527PubMedCrossRef
69.
Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE, Boonen A (2015) A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics. 33(3):205–224PubMedCrossRef
Metadata
Title
Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk
Authors
R.T.A.L. de Bot
H.D. Veldman
A.M. Witlox
L.W. van Rhijn
M. Hiligsmann
Publication date
01-07-2020
Publisher
Springer London
Published in
Osteoporosis International / Issue 7/2020
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-019-05252-8

Other articles of this Issue 7/2020

Osteoporosis International 7/2020 Go to the issue

Short Communication

Osteoporosis treatment gap in a prospective cohort of volunteer women

Short Communication

Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia

Original Article

Magnesium oxide and hip fracture in the elderly: a population-based retrospective cohort analysis

Original Article

Accelerometer-based prediction of skeletal mechanical loading during walking in normal weight to severely obese subjects

Original Article

Incidence of fractures in patients with type 1 diabetes mellitus—a retrospective study with 4420 patients

Original Article

Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis